These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32187518)

  • 21. Staphylococcal-associated molecular patterns enhance expression of immune defense genes induced by IL-17 in mammary epithelial cells.
    Bougarn S; Cunha P; Gilbert FB; Harmache A; Foucras G; Rainard P
    Cytokine; 2011 Dec; 56(3):749-59. PubMed ID: 22004923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options.
    Janiczek M; Szylberg Ł; Antosik P; Kasperska A; Marszałek A
    J Immunol Res; 2020; 2020():4910595. PubMed ID: 32537467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood.
    Zrioual S; Toh ML; Tournadre A; Zhou Y; Cazalis MA; Pachot A; Miossec V; Miossec P
    J Immunol; 2008 Jan; 180(1):655-63. PubMed ID: 18097068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A neutralizing antibody attenuates eosinophilic meningitis caused by Angiostrongylus cantonensis by involving IL-17RA/Traf6/NF-κB signaling.
    Feng Y; Zheng C; Zhou Z; Xiong H; Feng F; Xie F; Wu ZD
    Exp Cell Res; 2019 Nov; 384(1):111554. PubMed ID: 31415761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.
    Ho AW; Garg AV; Monin L; Simpson-Abelson MR; Kinner L; Gaffen SL
    PLoS One; 2013; 8(7):e70168. PubMed ID: 23922952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.
    Rong Z; Cheng L; Ren Y; Li Z; Li Y; Li X; Li H; Fu XY; Chang Z
    Cell Signal; 2007 Jul; 19(7):1514-20. PubMed ID: 17346928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and location of IL-17A, E, F and their receptors in colorectal adenocarcinoma: Comparison with benign intestinal disease.
    Liu Y; Sun X; Zhao X; An L; Wang Z; Jiang J; Shen W; Yang X; Sun Y
    Pathol Res Pract; 2018 Apr; 214(4):482-491. PubMed ID: 29548809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
    Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Cappelletti M; Huppert SS; Iwakura Y; Dong C; Shanmukhappa SK; Divanovic S
    PLoS One; 2016; 11(2):e0149783. PubMed ID: 26895034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer.
    Huang Q; Ma XC; Yang X; Wang W; Li Y; Lv Z; Corrigan CJ; Chen Y; Ying S
    J Biol Regul Homeost Agents; 2018; 32(5):1105-1116. PubMed ID: 30334403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organizing structural principles of the IL-17 ligand-receptor axis.
    Wilson SC; Caveney NA; Yen M; Pollmann C; Xiang X; Jude KM; Hafer M; Tsutsumi N; Piehler J; Garcia KC
    Nature; 2022 Sep; 609(7927):622-629. PubMed ID: 35863378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica.
    Zhang Y; Huang D; Gao W; Yan J; Zhou W; Hou X; Liu M; Ren C; Wang S; Shen J
    Int Immunol; 2015 Jul; 27(7):317-25. PubMed ID: 25840437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modeling and rational design of disulfide-stapled self-inhibitory peptides to target IL-17A/IL-17RA interaction.
    Huang W; Zhou Y; Pan C; Zhang X; Zhao H; Shen L
    J Mol Recognit; 2023 Aug; 36(8):e3045. PubMed ID: 37415317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-17A in lipid metabolism and atherosclerosis.
    Yu XH; Jiang N; Zheng XL; Cayabyab FS; Tang ZB; Tang CK
    Clin Chim Acta; 2014 Apr; 431():33-9. PubMed ID: 24508995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): preparation and evaluation in asthma mice.
    Lv Y; Zhang J; Wang C
    Bioengineered; 2021 Dec; 12(1):3029-3039. PubMed ID: 34180764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors.
    Liu S
    Adv Exp Med Biol; 2019; 1172():97-117. PubMed ID: 31628653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IL-17 cytokine family.
    Gaffen SL; Kramer JM; Yu JJ; Shen F
    Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
    Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
    Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses.
    Chang SH; Dong C
    Cell Res; 2007 May; 17(5):435-40. PubMed ID: 17452998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of interleukin-17F in asthma.
    Kawaguchi M; Kokubu F; Fujita J; Huang SK; Hizawa N
    Inflamm Allergy Drug Targets; 2009 Dec; 8(5):383-9. PubMed ID: 20025586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.